Indiana University School of Medicine, Division of Gastroenterology/Hepatology

Indianapolis, Indiana 46202

0 studies enrolling now · 1 studies all time

What they study most

Liver Fibrosis Due to NASH

Studies at this site

• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH — Stopped early